TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PRAXAIR INC

Pharmaceuticals
Pharma

PRAXAIR INC is a pharmaceutical company with 4 FDA-approved products.

2013
Since
4
Drugs
-
Trials
6
Approved (2yr)

Key Drugs

OXYGEN, USP
oxygen
· 2013
NITROGEN, NF
nitrogen
· 2013
CARBON DIOXIDE, USP
carbon dioxide
· 2013
HELIUM, USP
helium
· 2013

Recent Activity

CARBON DIOXIDE, USP 2025-10-25
CARBON DIOXIDE, USP 2025-06-16
CARBON DIOXIDE, USP 2025-04-21
Carbon Dioxide, USP 2025-02-02
Medical Gas
Carbon Dioxide, USP 2024-11-09
CARBON DIOXIDE, USP 2024-08-10
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...